Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.

Lysosomal Storage Diseases: From Pathophysiology to Therapy

Open access
Parenti, Giancarlo, Andria, Generoso, Ballabio, Andrea · 2015 · Annual Review of Medicine

Abstract

Lysosomal storage diseases are a group of rare, inborn, metabolic errors characterized by deficiencies in normal lysosomal function and by intralysosomal accumulation of undegraded substrates. The past 25 years have been characterized by remarkable progress in the treatment of these diseases and by the development of multiple therapeutic approaches. These approaches include strategies aimed at increasing the residual activity of a missing enzyme (enzyme replacement therapy, hematopoietic stem cell transplantation, pharmacological chaperone therapy and gene therapy) and approaches based on reducing the flux of substrates to lysosomes. As knowledge has improved about the pathophysiology of lysosomal storage diseases, novel targets for therapy have been identified, and innovative treatment approaches are being developed.

Overview

Integrity signals

Registry

Crossref · 10.1146/annurev-med-122313-085916

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 94 references

Research works printed but not linked: 2

  1. Shea L, 2009, Int. J. Clin. Pharmacol. Ther., 47, S42
  2. Ponder KP., 2008, J. Clin. Investig., 118, 2686

Cited by

  • Lysosomes as dynamic regulators of cell and organismal homeostasis

    Ballabio, A., & Bonifacino, J. S. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0185-4 · Cited by 1,469

    Self-citation
  • Lysosomal storage diseases

    Platt, F. M., d’Azzo, A., Davidson, B. L., Neufeld, E. F., & Tifft, C. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0025-4 · Cited by 1,052

  • TFEB at a glance

    Napolitano, G., & Ballabio, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.146365 · Cited by 845

    “A class of diseases that have been shown to benefit from TFEB overexpression are lysosomal storage disorders (LSDs), in which genetic defects in specific lysosomal proteins lead to accumulation of substrates in the lysosomal lumen (Parenti et al., 2015).”
    BackgroundSelf-citation
  • Lysosomes as a therapeutic target

    Bonam, S. R., Wang, F., & Muller, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0036-1 · Cited by 759

    “For example, in Gaucher disease, the sphingolipid glucocerebroside accumulates in cells (particularly macrophages) and organs, including the liver and spleen, owing to defi ciency in the enzyme GCase 24, 66 .”
    Background
  • Current clinical applications of in vivo gene therapy with AAVs

    Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743

    “Collectively, LSDs are relatively common disorders (1:5,000 to 1:5,500), although individually rare.229–231 LSDs affect multiple organ systems but have one defining system predominating, such as hypertrophic cardiomyopathy in patients with infantile Pompe disease, CNS deficits in children with CNL2, or hepatosplenomeg…”
    Background

See all 431

Metadata

Authors
Parenti, G., Andria, G., & Ballabio, A.
Affiliations
  • Federico II University Hospital (IT)
  • Baylor College of Medicine (US)
Corresponding author
Ballabio, Andrea
Venue
Annual Review of Medicine
Published
2015-01-14
Volume
66
Issue
1
Pages
471-486
ISSN
  • 0066-4219 (ISSN-L)
  • 1545-326X
OpenAlex
W2116572569
Cited by
404
References
94
Citations by year
2026: 16 · 2025: 29 · 2024: 36 · 2023: 32 · 2022: 41 · 2021: 39 · 2020: 44 · 2019: 43 · 2018: 30 · 2017: 39 · 2016: 40 · 2015: 15
FWCI
5.10
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
  • Health Sciences › Medicine › Nephrology › Biomedical Research and Pathophysiology
Keywords
lysosomal storage disease, inborn errors of metabolism, lysosomal dysfunction, substrate accumulation, enzyme replacement therapy, hematopoietic stem cell transplantation, pharmacological chaperone therapy, gene therapy, substrate reduction therapy, pathophysiology, rare diseases
MeSH terms
Humans, Genetic Therapy, Lysosomal Storage Diseases, Hematopoietic Stem Cell Transplantation, Molecular Chaperones, Enzyme Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lysosomal Storage Diseases: From Pathophysiology to Therapy. https://app.cochat.ai/papers/10.1146/annurev-med-122313-085916
The paper
Parenti, G., Andria, G., & Ballabio, A. (2015). Lysosomal Storage Diseases: From Pathophysiology to Therapy. Annual Review of Medicine. https://doi.org/10.1146/annurev-med-122313-085916

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.